NCT04927052View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Revanesse Shape + With Lidocaine Versus Juvederm Voluma With Lidocaine for the Correction of Age-Related Midface Volume Deficit / Lipoatrophy at 6 and 12 Months Post-treatment

NACompletedINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

April 21, 2021

Primary Completion Date

August 30, 2023

Study Completion Date

August 30, 2023

Conditions
Volume Deficit in the Mid-face
Interventions
DEVICE

Revanesse Shape + with Lidocaine

Revanesse Shape + with Lidocaine. Participants had 1 cheek treated with Revanesse Shape + with Lidocaine

DEVICE

Juvederm Voluma with Lidocaine.

Juvederm Voluma with Lidocaine. Participants had 1 cheek treated with Juvederm Voluma with Lidocaine

Trial Locations (7)

T2W 4X9

Laser Rejuvenation, Calgary

T6X 0N9

Alpha Research/Lucere Dermatology, Edmonton

L7N 3N2

Dermetics, Burlington

L6J 7W5

The Centre for Clinical Trials, Oakville

L4L 8E2

Bertucci MedSpa, Woodbridge

H7S 1M9

Victoria Park Medispa Laval, Laval

H3Z 1C3

Erevna Innovations, Westmount

All Listed Sponsors
lead

Prollenium Medical Technologies Inc.

INDUSTRY